Targeting SHP2 phosphatase in hematological malignancies.

Abstract excerpt

INTRODUCTION: Src homology-2-containing protein tyrosine phosphatase 2 (SHP2) is a ubiquitously expressed, non-receptor protein tyrosine phosphatase encoded by the PTPN11 gene. Gain-of-function (GOF) mutations in PTPN11 are associated with the development of various hematological malignancies and Noonan syndrome with multiple lentigines (NS-ML). Preclinical studies performed with allosteric SHP2 inhibitors and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hematologic Neoplasms
• Share to Mutation
• Share to PI3K/AKT/mTOR signaling in cancer